CXSS2300099 | 注射用重组(酵母分泌型)人血清白蛋白-人粒细胞集落刺激因子(I)融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2023-12-14 | | Jiangsu T-mab Bio-Pharmaceuticals Co Ltd | | | view |
CXSL2300724 | 重组人血清白蛋白注射液 | | Injection | Biological Products(1) | New Drug Application | 2023-10-24 | | Shandong Kingtone Biotechnology Co Ltd | | | view |
CXSS2400098 | 植物源重组人血清白蛋白注射液 | | Injection | Biological Products(1) | New Drug Application | 2024-09-12 | | Wuhan Healthgen BIOTECHNOLOGY Corp | | | view |
CXSB1900023 | 注射用重组人血清白蛋白/粒细胞刺激因子融合蛋白 | | Lyophilized | Biological Products | Supplementary Application | 2019-09-24 | 中美福源生物技术(北京)股份有限公司 | Fortune Rock (China) Co Ltd | In Review | 2019-09-23 | view |
CXHL1200640 | 注射用亚锡半乳糖酰人血清白蛋白二亚乙基三胺五乙酸盐 | | Lyophilized | Chemical Drugs(3.1) | New Drug Application | 2013-06-27 | 北京师宏药物研制中心 | Beijing Shihong Pharmaceutical Co Ltd | Certificate Issued | 2016-08-23 | view |
CXSL1200049 | 注射用重组人血清白蛋白/干扰素α2b融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2013-01-14 | 北京美福源生物医药科技有限公司 | Beijing Meifuyuan Biomedical Technology Co Ltd | Certificate Issued | 2015-10-13 | view |
CXSL1000031 | 注射用重组人血清白蛋白/干扰素α2a融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2010-11-01 | 天津林达生物科技有限公司 | Tianjin Linda Biotechnology Co Ltd | Certificate Issued | 2012-08-14 | view |
CXSB1900012 | 注射用重组人血清白蛋白/干扰素α2a融合蛋白 | | Lyophilized | Biological Products | Supplementary Application | 2019-06-12 | 天津林达生物科技有限公司 | Tianjin Linda Biotechnology Co Ltd | Certificate Issued | 2020-07-29 | view |
CXSL1700103 | 注射用重组人血清白蛋白/促红素融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2017-12-11 | 天津溥瀛生物技术有限公司 | Tianjin PuYing Biotechnology Co Ltd | Certificate Issued | 2018-05-24 | view |
CXSL1600060 | 注射用重组人血清白蛋白/促红素融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2016-12-30 | 天津溥瀛生物技术有限公司 | Tianjin PuYing Biotechnology Co Ltd | Certificate Issued | 2017-05-11 | view |
CXSL0900038 | 注射用重组人血清白蛋白/粒细胞刺激因子融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2009-12-18 | 天津溥瀛生物技术有限公司 | Tianjin PuYing Biotechnology Co Ltd | Certificate Issued | 2011-11-07 | view |
CXSL1700169 | 注射用重组人血清白蛋白与干扰素α-2b融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2018-05-15 | 山西康宝生物制品股份有限公司 | Shanxi Kangbao Biological Product Co Ltd | In Review | 2018-05-14 | view |
CXSB0600055 | 重组人血清白蛋白-干扰素α2b融合蛋白注射液 | | Injection | Biological Products | Supplementary Application | 2006-10-10 | 杭州九源基因工程有限公司 | Hangzhou Jiuyuan Gene Engineering Co Ltd | Certificate Issued | 2007-09-10 | view |
CXSB1200008 | 重组人血清白蛋白-干扰素α2b融合蛋白注射液 | | Injection | Biological Products | Supplementary Application | 2012-06-19 | 杭州九源基因工程有限公司 | Hangzhou Jiuyuan Gene Engineering Co Ltd | Certificate Issued | 2014-03-04 | view |
CXSB0600053 | 重组人血清白蛋白-干扰素α2b融合蛋白注射液 | | Injection | Biological Products | Supplementary Application | 2006-10-10 | 杭州九源基因工程有限公司 | Hangzhou Jiuyuan Gene Engineering Co Ltd | Certificate Issued | 2008-01-03 | view |
CXSB1200007 | 重组人血清白蛋白-干扰素α2b融合蛋白注射液 | | Injection | Biological Products | Supplementary Application | 2012-06-19 | 杭州九源基因工程有限公司 | Hangzhou Jiuyuan Gene Engineering Co Ltd | Certificate Issued | 2014-03-04 | view |
CXSL0500005 | 重组人血清白蛋白-干扰素α2b融合蛋白注射液 | | Injection | Biological Products(1) | New Drug Application | 2005-02-22 | 杭州九源基因工程有限公司 | Hangzhou Jiuyuan Gene Engineering Co Ltd | Certificate Issued | 2005-12-31 | view |
CXSB0600054 | 重组人血清白蛋白-干扰素α2b融合蛋白注射液 | | Injection | Biological Products | Supplementary Application | 2006-10-18 | 杭州九源基因工程有限公司 | Hangzhou Jiuyuan Gene Engineering Co Ltd | Certificate Issued | 2008-01-03 | view |
CXSB1200009 | 重组人血清白蛋白-干扰素α2b融合蛋白注射液 | | Injection | Biological Products | Supplementary Application | 2012-06-19 | 杭州九源基因工程有限公司 | Hangzhou Jiuyuan Gene Engineering Co Ltd | Certificate Issued | 2014-03-04 | view |
CXSB1900016 | 植物源重组人血清白蛋白注射液 | | Injection | Biological Products | Supplementary Application | 2019-07-30 | 武汉禾元生物科技股份有限公司 | Wuhan Healthgen BIOTECHNOLOGY Corp | In Review | 2019-07-29 | view |